Physician profile
Richard A Grochmal
NPI 1073599130
$904.40
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $474.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $270.86 | 2019-2020 | |
| Glaxosmithkline, LLC. | $81.26 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $76.17 | 2019-2020 | |
| Abbvie INC. | $66.39 | 2019-2020 | |
| Radius Health, INC. | $50.95 | 2019 | |
| Novo Nordisk INC | $46.77 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.13 | 2019-2020 | |
| Pfizer INC. | $38.50 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.65 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.59 | 2019-2020 | |
| Vivus LLC | $20.75 | 2020 | |
| Genentech USA, INC. | $20.00 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.37 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $16.79 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.76 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $15.68 | 2019 | |
| Sanofi Pasteur INC. | $14.97 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.08 | 2019 | |
| Ibsa Pharma INC. | $13.96 | 2020 | |
| Currax Pharmaceuticals LLC | $13.45 | 2020 | |
| Horizon Therapeutics Plc | $13.32 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Grochmal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.